Moderna and Merck’s Melanoma Vaccine Breakthrough | Burlington News

Burlington News Today | 2 Min News | The Daily News Now! · Aug 20, 2026 · 1m

Moderna and Merck just dropped a game-changing update: their custom mRNA melanoma vaccine, Intismeran, is showing major promise in Phase Three trials—when paired with Keytruda, it slashes the risk of cancer returning after surgery. This isn’t your average shot; it’s built from each patient’s tumor DNA, turning personalized medicine into real-world hope. For melanoma survivors, it’s a powerful new tool to fight recurrence—and a bold step toward smarter, targeted cancer care. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on…